Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

RCKT
Rocket Pharmaceuticals, Inc. Common Stock
stock NASDAQ

Market Open
Aug 11, 2026 1:34:25 PM EDT
3.48USD-4.258%(-0.16)929,260
3.48Bid   3.49Ask   0.01Spread
Pre-market
Aug 10, 2026 9:10:30 AM EDT
3.59USD-0.537%(-0.02)0
After-hours
Aug 10, 2026 4:59:30 PM EDT
3.68USD+0.960%(+0.04)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 11, 2022
07:09AM EST  Rocket Pharmaceuticals Highlights Anticipated 2022 Milestones Across Lentiviral And AAV Gene Therapy Clinical Programs   Benzinga
Jan 4, 2022
07:00AM EST  Rocket Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference   Business Wire
Dec 15, 2021
08:06AM EST  Chardan Capital Maintains Buy on Rocket Pharmaceuticals, Raises Price Target to $60   Benzinga
Dec 13, 2021
09:28AM EST  Rocket Pharmaceuticals Presents Clinical Data From Company's Lentiviral Gene Therapies For Treatment Of Fanconi Anemia, LAD-I And PKD At ASH 2021 Meeting   Benzinga
09:14AM EST  Rocket Presents Positive Data From Lentiviral Gene Therapies For Treatment Of Fanconi Anemia   RTTNews
09:00AM EST  Rocket Pharmaceuticals Presents Positive Clinical Data from Company's Lentiviral Gene Therapies for Treatment of Fanconi Anemia, LAD-I and PKD at the 63rd American Society of Hematology (ASH) Annual Meeting   Business Wire
Dec 8, 2021
07:15AM EST  Rocket Pharma Appoints Martin Wilson As General Counsel And Chief Compliance Officer   RTTNews
07:00AM EST  Rocket Pharmaceuticals Appoints Martin L. Wilson as General Counsel and Chief Compliance Officer   Business Wire
Dec 7, 2021
07:00AM EST  Rocket Pharmaceuticals to Host In-Person Investor and Analyst Event and Webcast on Tuesday, Dec. 14 at 7:30 a.m. ET to Discuss Updated Clinical Data Presented at the 63rd American Society of Hematology (ASH) Annual Meeting   Business Wire
Nov 22, 2021
07:00AM EST  Rocket Pharmaceuticals Announces Participation in Evercore ISI 4th Annual HEALTHCONx Virtual Conference   Business Wire
Nov 15, 2021
10:53AM EST  Rocket Pharma Provides Updates from its Phase 1 Clinical Trial of RP-A501 in Danon Disease   Benzinga
07:00AM EST  Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial of RP-A501 in Danon Disease   Business Wire
Nov 11, 2021
07:00AM EST  Rocket Pharmaceuticals to Host Webcast on Nov. 15 at 8:30 a.m. ET to Present Updated Danon Disease Clinical Data   Business Wire
Nov 10, 2021
07:00AM EST  Rocket Pharmaceuticals Announces Participation in Stifel 2021 Virtual Healthcare Conference   Business Wire
Nov 8, 2021
11:34AM EST  Rocket Pharma Early Monday Reported Will Give Updated Data From Ongoing Phase 1 Trial Of RP-A501 In Danon Disease At American Heart Association Sessions Nov. 13 At 8 a.m. EST   Benzinga
05:00AM EST  Rocket Pharmaceuticals Announces Danon Disease Presentation at the American Heart Association (AHA) Scientific Sessions 2021   Business Wire
Nov 4, 2021
09:00AM EDT  Rocket Pharmaceuticals Announces Presentations Highlighting Three Lentiviral Gene Therapies at the 63rd American Society of Hematology (ASH) Annual Meeting   Business Wire
Nov 3, 2021
09:15AM EDT  Rocket Pharmaceuticals Q3 EPS $(0.79) Down From $(0.53) YoY   Benzinga
07:31AM EDT  Rocket Pharma Q3 Net Loss $50.1 Mln Or $0.79/shr Vs. Loss $29.1 mln Or $0.53/shr Prior Year   RTTNews
07:00AM EDT  Rocket Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Progress   Business Wire
Oct 20, 2021
08:16AM EDT  The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review   Benzinga
08:03AM EDT  Rocket Pharma Posts Interim Data From Immunodeficiency Disorder Gene Therapy Trial   Benzinga
06:05AM EDT  Rocket Pharmaceuticals Highlights Presentation Of Updates From RP-L201 Phase 1/2 Trial At 28th Annual Congress of the European Society of Gene & Cell Therapy   Benzinga
03:24AM EDT  Rocket Pharma Announces Positive Clinical Data From RP-L201 Trial For Leukocyte Adhesion Deficiency-I At ESGCT   RTTNews
03:00AM EDT  Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)   Business Wire
Oct 19, 2021
06:06AM EDT  Rocket Pharmaceuticals Announces Presentations Highlighting Lentiviral Gene Therapies At 28th Annual Congress Of The European Society Of Gene & Cell Therapy Oct. 20-22   Benzinga
06:00AM EDT  Rocket Pharmaceuticals Announces Presentations Highlighting Lentiviral Gene Therapies at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)   Business Wire
Oct 7, 2021
07:00AM EDT  Rocket Pharmaceuticals to Present at the 2021 Cell & Gene Meeting on the Mesa   Business Wire
Sep 30, 2021
07:00AM EDT  Rocket Pharmaceuticals to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference   Business Wire
Sep 14, 2021
07:05AM EDT  Rocket Pharmaceuticals Highlights Presentation Of Clinical Data From RP-A501 Trial In Danon Disease At Heart Failure Society Of America (HFSA) Annual Scientific Meeting 2021   Benzinga
07:00AM EDT  Rocket Pharmaceuticals Presents Clinical Data from RP-A501 Trial in Danon Disease at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2021   Business Wire
Sep 10, 2021
07:00AM EDT  Rocket Pharmaceuticals Announces Upcoming Danon Disease Presentation at the Heart Failure Society of America Annual Scientific Meeting 2021   Business Wire
Sep 7, 2021
07:00AM EDT  Rocket Pharmaceuticals Appoints Isabel Carmona, J.D., as Chief Human Resources Officer   Business Wire
Aug 30, 2021
07:12AM EDT  Rocket Pharma Announces $26.4M Common Stock Private Placement   Benzinga
07:00AM EDT  Rocket Pharmaceuticals Announces $26.4 Million Private Placement   Business Wire
Aug 16, 2021
02:00PM EDT  FDA Lifts Clinical Hold On Rocket Pharma's X-Linked Inherited Disorder Trial   Benzinga
07:24AM EDT  Rocket Pharmaceuticals, Inc. (RCKT) announced Monday that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on the Company's Phase 1 clinical trial of RP-A501 for the treatment of Danon Disease, allowing patient enrollment to resume.   RTTNews
07:08AM EDT  Rocket Pharma Announces FDA Lifts Clinical Hold On Phase 1 Clinical Trial Of RP-A501 For Danon Disease   RTTNews
07:01AM EDT  Rocket Pharmaceuticals Announces FDA Lifts Clinical Hold on Danon Disease Trial of RP-A501   Benzinga
Aug 10, 2021
04:39AM EDT  SVB Leerink Maintains Outperform on Rocket Pharmaceuticals, Lowers Price Target to $62   Benzinga
Aug 9, 2021
04:26PM EDT  Rocket Pharmaceuticals Q2 EPS $(0.55) Down From $(0.45) YoY   Benzinga
04:01PM EDT  Rocket Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Progress   Business Wire
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
04:11AM EDT  Earnings Scheduled For August 9, 2021   Benzinga
Aug 8, 2021
10:11AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Aug 3, 2021
04:02PM EDT  Rocket Pharmaceuticals to Host Conference Call on Aug. 9 at 4:30 p.m. ET to Discuss Second Quarter Results and Recent Business Highlights   Business Wire
May 13, 2021
12:00PM EDT  Rocket Pharmaceuticals Announces Positive Data From RP-L102, RP-L201 Gene Therapy Programs   Benzinga
07:05AM EDT  Rocket Pharma Presents Clinical Data From Fanconi Anemia, Leukocyte Adhesion Deficiency-I, Pyruvate Kinase Deficiency Programs at Meeting of American Society of Gene and Cell Therapy: Showed Evidence Of Prelim. Engraftment In At Least 6 Of 9 Patients   Benzinga
May 12, 2021
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
May 11, 2021
12:28PM EDT  Rocket Pharma Stock Drops After FDA Institutes Clinical Hold On RP-A501 Danon Disease Trial   Benzinga
07:54AM EDT  The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings   Benzinga
May 10, 2021
04:04PM EDT  Rocket Pharmaceuticals Q1 EPS $(0.65) Down From $(0.45) YoY   Benzinga
May 3, 2021
10:40AM EDT  Expected Moves: Draftkings, Square, Roku, AMC, Peloton, Moderna, Rocket, Uber, Cronos And More   Benzinga
Apr 27, 2021
04:52PM EDT  Rocket Pharmaceuticals Announces Upcoming Clinical Data Presentations at the 24th Annual Meeting of the American Society of Gene and Cell Therapy   Benzinga
Apr 14, 2021
07:10AM EDT  Rocket Reports Positive Long-Term Clinical Data From RP-L201 Trial For Leukocyte Adhesion Deficiency-I   RTTNews
07:01AM EDT  Rocket Pharmaceuticals Reports Positive Long-Term Clinical Data from RP-L201 Trial for the Treatment of Leukocyte Adhesion Deficiency-I at the Clinical Immunology Society 2021 Annual Meeting   Business Wire
Apr 1, 2021
06:43AM EDT  SVB Leerink Maintains Outperform on Rocket Pharmaceuticals, Raises Price Target to $66   Benzinga
Mar 29, 2021
07:17AM EDT  Rocket Pharma Gets EMA PRIME Designation For RP-L201 Gene Therapy For Treatment Of Leukocyte Adhesion Deficiency-I   RTTNews
07:11AM EDT  Rocket Pharmaceuticals Receives EMA Priority Medicines Designation for RP-L201 Gene Therapy for Treatment of Leukocyte Adhesion Deficiency-I   Benzinga
07:00AM EDT  Rocket Pharmaceuticals Receives EMA Priority Medicines (PRIME) Designation for RP-L201 Gene Therapy for Treatment of Leukocyte Adhesion Deficiency-I   Business Wire
Mar 22, 2021
07:04AM EDT  Rocket Pharmaceuticals Announces Updated Positive Preliminary Clinical Data from Phase 1 Trial of RP-L301 for the Treatment of Pyruvate Kinase Deficiency   Benzinga
Mar 9, 2021
09:16AM EST  Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy Designation For RP-L201 Gene Therapy For Leukocyte Adhesion Deficiency-I   Benzinga
Mar 2, 2021
01:34PM EST  Stifel Initiates Coverage On Rocket Pharmaceuticals with Buy Rating, Announces Price Target of $64   Benzinga
Feb 25, 2021
07:17AM EST  Rocket Pharmaceuticals Q4 EPS $(1.08) Down From $(0.39) YoY   Benzinga
Feb 18, 2021
10:02AM EST  Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2021   Benzinga
05:49AM EST  Needham Initiates Coverage On Rocket Pharmaceuticals with Buy Rating, Announces Price Target of $75   Benzinga
Feb 9, 2021
08:10AM EST  The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement   Benzinga
Feb 5, 2021
07:44AM EST  The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street   Benzinga
Jan 11, 2021
07:06AM EST  Rocket Pharmaceuticals Announces Buildout of R&D and Manufacturing Facility to Support Development of Innovative Gene Therapy Pipeline   Benzinga
Jan 8, 2021
07:25AM EST  The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs   Benzinga
Dec 15, 2020
05:58AM EST  Rocket Pharmaceuticals Director Naveen Yalamanchi Reported Purchase of 247,720 Shares @ Avg Price of $56/Share in Form 4 Filing on Monday   Benzinga
Dec 11, 2020
08:11AM EST  The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street   Benzinga
Dec 10, 2020
07:42AM EST  The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations   Benzinga
05:47AM EST  Rocket Pharmaceuticals Priced Upsized ~4.64M Share Public Offering of Common Stock @$56/Share   Benzinga
Dec 9, 2020
02:55PM EST  Mid-Afternoon Market Update: Nasdaq Tumbles 2%; DoorDash Shares Spike Higher   Benzinga
12:23PM EST  Mid-Day Market Update: Dow Drops Over 100 Points; Rocket Pharmaceuticals Shares Jump   Benzinga
10:23AM EST  Mid-Morning Market Update: Markets Mixed; Campbell Soup Profit Tops Views   Benzinga
08:33AM EST  Chardan Capital Maintains Buy on Rocket Pharmaceuticals, Raises Price Target to $56   Benzinga
07:52AM EST  Rocket Pharmaceuticals Announces $175M Public Offering of Common Stock   Benzinga
Dec 8, 2020
04:00PM EST  Rocket Pharma Reports Gene Expression, Clinical Biomarker, Prelim. Functional Data From Phase 1 Trial Of RP-A501 For Treatment Of Danon Disease   Benzinga
10:06AM EST  Chardan Capital Maintains Buy on Rocket Pharmaceuticals, Raises Price Target to $46   Benzinga
09:36AM EST  Benzinga's Top Upgrades, Downgrades For December 8, 2020   Benzinga
06:47AM EST  Oppenheimer Downgrades Rocket Pharmaceuticals to Perform   Benzinga
Dec 7, 2020
02:31PM EST  Rocket Pharmaceuticals Presents Positive Clinical Data from Fanconi Anemia And Leukocyte Adhesion Deficiency-I Programs At ASH 2020   Benzinga
Dec 6, 2020
08:41AM EST  Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace   Benzinga
Nov 20, 2020
08:06AM EST  The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger   Benzinga
Nov 19, 2020
08:17AM EST  The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway   Benzinga
Nov 18, 2020
07:30AM EST  The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted   Benzinga
Nov 13, 2020
07:05AM EST  Rocket Pharmaceuticals Receives $3.7M Clinical Grant To Fund Phase 1 Clinical Trial Of RP-L401 For Infantile Malignant Osteopetrosis   Benzinga
Nov 5, 2020
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
Nov 4, 2020
10:38AM EST  Rocket Pharma To Present Data From Fanconi Anemia, Leukocyte Adhesion Deficiency-I, Pyruvate Kinase Deficiency Programs At American Society Of Hematology Meeting Dec. 7   Benzinga
07:02AM EST  Rocket Pharmaceuticals Q3 EPS $(0.53) Down From $(0.38) YoY   Benzinga
Oct 16, 2020
11:57AM EDT  Chardan Capital Maintains Buy on Rocket Pharmaceuticals, Raises Price Target to $35   Benzinga
07:05AM EDT  Rocket Pharmaceuticals Highlights Presentation Of LAD-l Clinical Update And Comprehensive IMO Preclinical Review At European Society For Immunodeficiencies 2020 Meeting   Benzinga
Sep 2, 2020
07:12AM EDT  Rocket Pharmaceuticals Says First Patient Treated In Higher Dose Cohort In Phase 1 Clinical Trial Of RP-A501   RTTNews
07:01AM EDT  Rocket Pharmaceuticals Announces First Patient Treated In Higher Dose Cohort In Phase 1 Clinical Trial Of RP-A501 For Danon Disease   Benzinga
Aug 27, 2020
07:01AM EDT  Rocket Pharmaceuticals Receives FDA Fast Track Designation For RP-L401 Gene Therapy For Infantile Malignant Osteopetrosis   Benzinga
Aug 26, 2020
07:01AM EDT  Rocket Pharmaceuticals Expands Clinical Sites for its FA, Danon, LAD-I and IMO Trials   Benzinga
Aug 14, 2020
08:26AM EDT  The Daily Biotech Pulse: Adcom Rules In Favor Of Mesoblast, CureVac IPO, Novavax Clinches UK COVID-19 Vaccine Deal   Benzinga
Jul 13, 2020
07:10AM EDT  Rocket Pharmaceuticals Announces First Patient Treated in Phase 1 Trial of RP-L301 Gene Therapy for Pyruvate Kinase Deficiency   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC